
Epricin 10mg Injection
Marketer
Shantha Biotech
Salt Composition
Epirubicin (10mg)
Overview Epricin 10mg Injection
Epricin 10mg Injection treats various blood cancers, as well as cancers affecting the breast, stomach, lung, ovaries, and soft tissues. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, this medication may be used alone or in conjunction with other drugs as part of combination chemotherapy. Dosage and frequency are determined by your physician based on your condition and may adjust over time. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse effects. While benefits may not be apparent for weeks or months, discontinue use only under your doctor's guidance. Because it reduces contraceptive efficacy, reliable birth control is recommended for both men and women during treatment. Common side effects include nausea, low platelet count, alopecia, amenorrhea, fever, and skin rashes. The medication can decrease blood cell counts, increasing infection risk, which can be life-threatening. Regular blood tests monitoring blood cell levels, along with kidney, liver, and heart function, are essential. Prior to commencing treatment, disclose any liver or heart conditions, and provide a complete list of all medications you are currently taking, as interactions may impact Epricin's efficacy. Inform your doctor if you are pregnant or breastfeeding.
Uses of Epricin 10mg Injection
Malignancy
Major Benefits of Epricin 10mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Epricin 10mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epricin 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Epricin 10mg Injection works:
Epricin 10mg Injection is a chemotherapeutic agent used in the treatment of breast cancer. Its mechanism of action involves inhibiting topoisomerase II, a crucial enzyme for DNA replication in cancer cells. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, ultimately hindering breast cancer cell proliferation and inducing cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Epricin 10mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Epricin 10mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might deem its use necessary if the potential advantages outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Epricin 10mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
Driving ability may be compromised by side effects of Epricin 10mg Injection, such as nausea and vomiting, which can cause temporary impairment.
KidneySAFE IF PRESCRIBED
The use of Epricin 10mg Injection in individuals with kidney impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is advised. For patients exhibiting serum creatinine exceeding 5 mg/dL, reduced dosages might be appropriate.
LiverCAUTION
Individuals with hepatic impairment should use Epricin 10mg Injection cautiously, potentially requiring dose modification. Consultation with a physician is advised. Epricin 10mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Epricin 10mg Injection :
NA
Facts to Know About Epricin 10mg Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline-based drug |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Action Class | Cytotoxic alkaloids |
